- Home
- FBRX vs KRAQ Comparison
FBRX vs KRAQ Comparison
Compare FBRX & KRAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBRX | KRAQ |
|---|---|---|
| Founded | N/A | 2025 |
| Country | United States | United States |
| Employees | N/A | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 427.8M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | FBRX | KRAQ |
|---|---|---|
| Price | $22.25 | $9.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 194.1K | 47.1K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.78 | $9.78 |
| 52 Week High | $35.80 | $9.99 |
Technical Indicators
Market Signals| Indicator | FBRX | KRAQ |
|---|---|---|
| Relative Strength Index (RSI) | 40.01 | 50.58 |
| Support Level | $10.38 | $9.87 |
| Resistance Level | $22.61 | $9.92 |
| Average True Range (ATR) | 2.22 | 0.03 |
| MACD | -0.51 | 0.00 |
| Stochastic Oscillator | 27.81 | 44.44 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About KRAQ KRAKacquisition Corp Class A Ordinary Shares
Krakacquisition Corp is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.